GILD Gilead Sciences, Inc.
Healthcare
Price
$135.00
Intrinsic value
$63.56
Buy price
$50.85
Discount
-112.4%
DCF walkthrough
Near-term growth (g1)2.57%
Terminal growth (g2)3.50%
Years of g1 growth4
Discount rate9.00%
Margin of safety20.00%
- Operating CF
- $13,552,000,000.00
- Total debt
- $26,246,000,640.00
- Cash & STI
- $4,881,999,872.00
- Shares out.
- 1,243,000,000
Overvalued [LOW CF reliability]
Intrinsic value$63.57
Buy price (with MOS)$50.86
Current price$135.00
Discount to intrinsic value-112.4%
7-step quality scorecard
ROE quality
HIGH_VOLATILE- Average ROE
- 21.6%
- Current ROE
- 37.5%
- Minimum ROE
- 2.5%
Debt quality
LEVERAGED- Debt / Equity
- 1.16x
Moat proxy
MODERATE_PROXYCash-flow reliability
LOW- Operating CF / Net income
- —
Technical chart
Confluence: DOWNTREND (2/3)Weekly candles, ~3 years. Yellow line: 10-week EMA. Dashed lines: Fibonacci retracement of the last 52-week swing. Green arrow: an active DR1 support reclaim.
Assumptions & data quality
- Data source
- yfinance
- Growth (g1) source
- min(revenueCAGR,cfCAGR)
- Valuation model
- DCF_OCF
- Debt as % of DCF PV
- 26.2%
- Public economic interest
- 100.4%
These are model outputs built on assumptions (growth rate, discount rate, margin of safety), not facts - trust but verify, especially for LOW cash-flow-reliability or UNKNOWN-quality rows.